Tami Wisniewski

Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib

Thomas Yau, Yoon‐Koo Kang, Tae‐You Kim et al. · JAMA Oncology · 2020 · 1.2K citations · Full text

Pharmacy, Oncology, Pharmacotherapy +15

CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis

Masatoshi Kudo, Ana Matilla, Armando Santoro et al. · Journal of Hepatology · 2021 · 226 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Resource utilization and costs associated with chemotherapy-induced nausea and vomiting (CINV) following highly or moderately emetogenic chemotherapy administered in the US outpatient hospital setting

Thomas Burke, Tami Wisniewski, Frank R. Ernst · Supportive Care in Cancer · 2010 · 108 citations

Medicine, Oncology, Pharmacoeconomics +14

Administration Burden Associated With Recombinant Human Growth Hormone Treatment: Perspectives of Patients and Caregivers

Dianne Kremidas, Tami Wisniewski, Victoria Divino et al. · Journal of Pediatric Nursing · 2012 · 47 citations

Pharmacy, Endocrinology, Endocrine Pharmacotherapy +9

Primary care physicians’ utilization of type 2 diabetes screening guidelines and referrals to behavioral interventions: a survey-linked retrospective study

Sandhya Mehta, Michelle Mocarski, Tami Wisniewski et al. · BMJ Open Diabetes Research & Care · 2017 · 35 citations · Full text

Medicine, Family Medicine, Preventive Medicine +17